DMECON
The computed 12-month bankruptcy probability of DMECON is 2.2% (moderate). The 2024 annual accounts show equity of €27k and a net result of €24k. Its solvency ranks better than 17% of 656 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €27k |
| Net result | €24k |
| Better than sector | 17% |
| Active | 2 yrs |
Mixed profile: strong on profitability, weaker on solvency.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 11.4% | 42.7% | |
| Net result | €24k | €14k | |
| Equity | €27k | €39k | |
| Gross operating margin | €53k | €34k | |
| Total assets | €236k | €94k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €48k |
| Net profit | €24k |
| Cash flow | €38k |
| Staff costs | - |
| Income taxes | €5k |
| Dividends | - |
| Total assets | €236k |
| Equity | €27k |
| Debt | €209k |
| of which ≤ 1y | €126k |
| of which > 1y | €83k |
| Working capital | €-77k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 0.39 |
| Quick ratio | 0.39 |
| Working capital ratio | -32.8% |
| Solvency | 11.4% |
| Debt / equity | 7.75 |
| Long-term debt ratio | 3.08 |
| Interest coverage | 9.33 |
| Gross margin | - |
| Net margin | - |
| ROA | 10.2% |
| ROE | 88.9% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €236k |
| Fixed assets | 21/28 | €187k |
| Intangible fixed assets | 21 | €799 |
| Tangible fixed assets | 22/27 | €187k |
| Current assets | 29/58 | €49k |
| Amounts receivable within one year | 40/41 | €21k |
| Cash & bank | 54/58 | €11k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €236k |
| Equity | 10/15 | €27k |
| Contributions / capital | 10/11 | €3k |
| Reserves | 13 | €24k |
| Amounts payable | 17/49 | €209k |
| Amounts payable after one year | 17 | €83k |
| Amounts payable within one year | 42/48 | €126k |
| Trade debts payable within one year | 44 | €11k |
| Income statement | ||
| Gross operating margin | 9900 | €53k |
| Operating result | 9901 | €34k |
| Financial income | 75 | €58 |
| Financial charges | 65 | €5k |
| Result before taxes | 9903 | €28k |
| Income taxes | 67/77 | €5k |
| Net result for the period | 9904 | €24k |
| Result to be appropriated | 9905 | €24k |
| NACE primary | 33120 |
| Legal form | Private limited company(610) |
| Incorporation | 05-09-2023 |
| Status | Active |
| Postal code | 9630 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 45046A0410/00E002 | Flanders | 1,121 m² | - | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
24-05-2024 Hauters Jolien appointed as director
- Hauters Jolien, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Hauters Jolien",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2024-04-01",
"evidence_quote": "De bijzondere algemene vergadering beslist met eenparigheid van stemmen om Hauters Jolien te benoemer tot bestuurder met ingang vanaf 01/04/2024.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Zwalm",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-05-24",
"filing_date": "2024-05-14",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "bijzondere_algemene_vergadering",
"date": "2024-04-01",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0805.493.740",
"name_full": "DMECON",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "De Meulenaere Bart",
"org_rep_person_name": null,
"person_role_at_subject": "bestuurder"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | DMECON |
| Trade nameNL | DMECON |